Zepp Health (ZEPP) Research & Development (2016 - 2026)

Zepp Health has reported Research & Development for 11 years, with the latest figure at -$11.5 million in Q2 2026.

• On a quarterly basis, Research & Development fell 3.48% year-over-year to -$11.5 million in Q2 2026; TTM through Jun 2026 was -$46.5 million, a 2.22% decrease from a year earlier, with the FY2025 full-year figure at $45.3 million, down 1.82% from the prior year.
• Research & Development was -$11.5 million for Q2 2026 at Zepp Health, up from -$13.1 million in the prior quarter.
• The five-year high for Research & Development was -$10.4 million in Q3 2023, with the low at -$23.1 million in Q1 2022.
• Average Research & Development over 5 years is -$13.6 million, with a median of -$12.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Research & Development slumped 199.33% in 2022, then surged 42.12% in 2023.
• Over 5 years, Research & Development stood at -$16.6 million in 2022, then soared by 32.9% to -$11.1 million in 2023, then gained by 0.57% to -$11.1 million in 2024, then gained by 0.71% to -$11.0 million in 2025, then slipped by 5.13% to -$11.5 million in 2026.
• The last three Research & Development figures came in at -$11.5 million (Q2 2026), -$13.1 million (Q1 2026), and -$11.0 million (Q4 2025), per Business Quant data.